Attorney General William Tong announced enforcement actionsagainst two online distributors of bootleg GLP-1 weight loss drugs. Both sell“research grade” GLP-1 peptides direct to Connecticut consumers for weight losswithout prescriptions or any medical oversight. “Research Grade” GLP-1s are notFDA approved for human use, and studies have found that bootleg GLP-1s cancontain impurities, potential bacterial contamination, and inconsistentquantities of active ingredients, which can result in medication overdoses. Thelawsuit names Triggered Brand, a Florida-based company, alleging violations ofthe Connecticut Unfair Trade Practices Act and statutes prohibiting thepractice of pharmacy without a license. While Triggered Brand nominally claimsto sell lab supplies, its social media marketing and Trigged Brand’s websiteexplicitly target consumers looking for GLP-1 weight loss injections. Thecomplaint seeks civil penalties of up to $5,000 for each violation. “Onlinebootleggers and compounding pharmacies are taking advantage of the massivedemand for affordable weight loss treatment. These products are unauthorizedand may be unsafe, and we are taking action to warn providers, to stop the flowof illegal medications into Connecticut, and to hold bad actors accountable. Donot buy these meds online without a prescription. Talk to your doctor andpharmacy, and do not take risks with these untested and potentially adulteratedknockoffs.” – AG Tong